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Sir, 
Systemic sclerosis (SSc)-related digital ulcers (DU) are painful, and disabling[1-3], and digital ulcer 
burden is often the primary outcome measure in clinical trials of SSc-related digital vasculopathy[4]. 
This is despite several studies showing a lack of agreement between rheumatologists as to what 
constitutes a DU[5-8].  
Objective outcome measures of SSc-related DUs for tracking change over time are therefore 
urgently required for clinical practice and research studies. The application of digital planimetry to 
clinical DU photographs has shown the possibility of fine-grained measurement of DU characteristics 
(area)[9]. Our aims were to: (1) demonstrate the feasibility of patients with SSc-related DUs/digital 
lesions photographing their lesions using smartphone cameras, and (2) use digital planimetry-style 
software analysis on images collected from patients to measure and track lesion area as a marker of 
healing or progression. 
Patients with SSc-related digital lesions (judged to be ulcers by an experienced clinician) were asked 
to photograph their lesion(s) daily, using their own smartphone, for a maximum of 35 days. All 
patients gave written, informed consent. All patients were taking vasodilators, and 1 was on 
immunosuppressant therapy (methotrexate). The patients received normal clinical wound care 
throughout the study period, after which images were collected in-person, and stored securely for 
further analysis (see Figure 1 for examples). 
Time and date stamps were extracted for each patient image sequence to accurately describe 
chronology. Images were loaded into custom digital planimetry software[9] and initially calibrated 
using a fixed-size object (often the finger width) to allow comparison between images in the 
sequence. For each image, the lesion area was measured by fitting an elliptical shape to the outline 
of the lesion by a single observer (Figure 1). Using the calibration information, areas from each 
image were finally normalised to the area measured in the first image in the sequence. 
Image sequences were collected from four patients describing a total of seven lesions (one patient 
with three lesions, one patient with two lesions, two patients with one lesion). The median (range) 
sequence duration was 29 (13-35) days, and for number of images recorded/day 0.63 (0.31-1.00). 
The relative area time course for each lesion is shown in Figure 2. On average, lesion areas had, by 
study’s end, reduced to 56% of the area measured on day 1, with six out of seven lesions reducing in 
size over the time course. 
This pilot study confirms that it is feasible for patients to monitor their own lesions over an extended 
period (weeks) by taking photographs with their smartphone camera. Photographs were taken on 
approximately 2 out of every 3 days during the study period, suggesting patients were highly 
engaged in the process. Collected photographs were of analysable quality.  
This study therefore suggests a potential new tool for monitoring of lesion status/healing, both in 
the clinical setting, and as an outcome measure in clinical trials of SSc-related digital vasculopathy. 
Further work involving larger numbers of patients is now required to validate measurements 
produced, and to improve data collection by integrating imaging into a smartphone application. 
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Figure legends 
 
Figure 1. Selected examples of DU/lesion images taken from 3 sequences. Sequences demonstrate 
the varying quality of images captured by patients (particularly the bottom sequence where there 
are focus issues), although all were acceptable for further quantitative analysis. Top (L to R): days 1, 
24, and 35; Middle (L to R): days 1, 4, and 12; Bottom (L to R): days 2, 7 and 18. Lesions are 
represented by sequences 4, 5 and 6 in Figure 2 (top to bottom respectively). Top right image 
includes example of fitted ellipse shape (yellow outline) from software analysis. 
  
 Figure 2. Relative area time course plots for each of 7 digital lesions. Dashed red lines indicate 100% 
area, relative to the area measured on day 1. Lesion areas all reduced except for lesion 3 (top right). 
 
 
